Longitudinal Antigenic Sequences and Sites from Intra-Host Evolution (LASSIE) Identifies Immune-Selected HIV Variants.

Published online

Journal Article

Within-host genetic sequencing from samples collected over time provides a dynamic view of how viruses evade host immunity. Immune-driven mutations might stimulate neutralization breadth by selecting antibodies adapted to cycles of immune escape that generate within-subject epitope diversity. Comprehensive identification of immune-escape mutations is experimentally and computationally challenging. With current technology, many more viral sequences can readily be obtained than can be tested for binding and neutralization, making down-selection necessary. Typically, this is done manually, by picking variants that represent different time-points and branches on a phylogenetic tree. Such strategies are likely to miss many relevant mutations and combinations of mutations, and to be redundant for other mutations. Longitudinal Antigenic Sequences and Sites from Intrahost Evolution (LASSIE) uses transmitted founder loss to identify virus "hot-spots" under putative immune selection and chooses sequences that represent recurrent mutations in selected sites. LASSIE favors earliest sequences in which mutations arise. With well-characterized longitudinal Env sequences, we confirmed selected sites were concentrated in antibody contacts and selected sequences represented diverse antigenic phenotypes. Practical applications include rapidly identifying immune targets under selective pressure within a subject, selecting minimal sets of reagents for immunological assays that characterize evolving antibody responses, and for immunogens in polyvalent "cocktail" vaccines.

Full Text

Duke Authors

Cited Authors

  • Hraber, P; Korber, B; Wagh, K; Giorgi, EE; Bhattacharya, T; Gnanakaran, S; Lapedes, AS; Learn, GH; Kreider, EF; Li, Y; Shaw, GM; Hahn, BH; Montefiori, DC; Alam, SM; Bonsignori, M; Moody, MA; Liao, H-X; Gao, F; Haynes, BF

Published Date

  • October 21, 2015

Published In

Volume / Issue

  • 7 / 10

Start / End Page

  • 5443 - 5475

PubMed ID

  • 26506369

Pubmed Central ID

  • 26506369

Electronic International Standard Serial Number (EISSN)

  • 1999-4915

Digital Object Identifier (DOI)

  • 10.3390/v7102881

Language

  • eng

Conference Location

  • Switzerland